Journal Scan

Analysis compares teprotumumab vs intravenous methylprednisolone vs placebo in TED

Results from a meta-analysis suggest that the use of intravenous methylprednisolone (IVMP) in patients with thyroid eye disease (TED) may result in modest or not clinically relevant changes from baseline in proptosis and diplopia compared with placebo, while teprotumumab, compared with IVMP, was associated with greater improvements. In this matched-adjusted...